Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors

Journal of Neurochemistry

Volumn 96, Issue 4, 2006, Pages 1111-1120

  Gilsbach, R ^a   Faron Gorecka A ^c   Rogoz Z ^c   Bruss M ^a   Caron, M G ^b   Dziedzicka Wasylewska, M ^c   Bonisch H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Alpha adrenergic receptor; Autoradiography; Clonidine; Norepinephrine transporter knockout; Quantitative real time polymerase chain reaction; RX821002

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; BETA ACTIN; CLONIDINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESSENGER RNA; NORADRENALIN TRANSPORTER; RAUWOLSCINE; RECEPTOR SUBTYPE; TRITIUM;

ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG RECEPTOR BINDING; GENE EXPRESSION; HIPPOCAMPUS; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THALAMUS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BASE SEQUENCE; BRAIN; CLONIDINE; DNA PRIMERS; IDAZOXAN; MICE; MICE, KNOCKOUT; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, ALPHA-2; RNA, MESSENGER;

ANIMALIA;

EID: 33645096730     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03598.x     Document Type: Article

References (65)

1. Asakura M. Tsukamoto T. Hasegawa K. 1982 Modulation of rat brain alpha 2- and beta-adrenergic receptor sensitivity following long-term treatment with antidepressants Brain Res 235 192 197
2. Bohn LM. Xu F. Gainetdinov RR. Caron MG. 2000 Potentiated opioid analgesia in norepinephrine transporter knock-out mice JNeurosci 20 9040 9045
3. Bönisch H. Brüss M. 1994 The noradrenaline transporter of the neuronal plasma membrane AnnN Y AcadSci 733 193 202
4. Bücheler MM. Hadamek K. Hein L. 2002 Two alpha (2)-adrenergic receptor subtypes, alpha (2A) and alpha (2C), inhibit transmitter release in the brain of gene-targeted mice Neuroscience 109 819 826
5. Callado LF. Gabilondo AM. Meana JJ. 1999 Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment Life Sci 64 2327 2339
6. Campbell IC. McKernan RM. 1986 Clorgyline and desipramine alter the sensitivity of [3H]noradrenaline release to calcium but not to clonidine Brain Res 372 253 259
7. Carboni E. Silvagni A. 2004 Dopamine reuptake by norepinephrine neurons: exception or rule? CritRevNeurobiol 16 121 128
8. Cooper JR. Bloom FE. Roth HR. 2002 The Biochemical Basis of Neuropharmacology Oxford University Press Oxford
9. Cryan JF. Markou A. Lucki I. 2002 Assessing antidepressant activity in rodents: recent developments and future needs Trends PharmacolSci 23 238 245
10. Dziedzicka-Wasylewska M. Rogoz Z. Margas W. Dlaboga D. Goralska M. 2001 Some behavioural effects of antidepressant drugs are time-dependent ProgNeuropsychopharmacolBiolPsychiatry 25 373 393
11. Fagerholm V. Philipp M. Hein L. Scheinin M. 2004 [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice EurJPharmacol 497 301 309
12. Foote SL. Bloom FE. Aston-Jones G. 1983 Nucleus locus ceruleus: new evidence of anatomical and physiological specificity PhysiolRev 63 844 914
13. Frazer A. 2000 Norepinephrine involvement in antidepressant action JClinPsychiatry 61 25 30
14. Fritz JD. Jayanthi LD. Thoreson MA. Blakely RD. 1998 Cloning and chromosomal mapping of the murine norepinephrine transporter JNeurochem 70 2241 2251
15. Garcia AS. Barrera G. Burke TF. Ma S. Hensler JG. Morilak DA. 2004 Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment JNeurochem 91 683 693
16. Gobert A. Billiras R. Cistarelli L. Millan MJ. 2004 Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors JNeurosciMeth 140 141 152
17. Gould GG. Pardon MC. Morilak DA. Frazer A. 2003 Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems Neuropsychopharmacology 28 1633 1641
18. Gray AM. Pache DM. Sewell RD. 1999 Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? EurJPharmacol 378 161 168
19. Green AR. 1987 Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters Neuropharmacology 26 815 822
20. Greenbaum D. Colangelo C. Williams K. Gerstein M. 2003 Comparing protein abundance and mRNA expression levels on a genomic scale Genome Biol 4 117
21. Hahn MK. Robertson D. Blakely RD. 2003 A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters JNeurosci 23 4470 4478
22. Happe HK. Coulter CL. Gerety ME. Sanders JD. O'Rourke M. Bylund DB. Murrin LC. 2004 Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study Neuroscience 123 167 178
23. Heal DJ. Prow MR. Buckett WR. 1989 Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic alpha 2-adrenoceptors in the brain EurJPharmacol 170 19 28
24. Holmberg M. Scheinin M. Kurose H. Miettinen R. 1999 Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry Neuroscience 93 1323 1333
25. Holmberg M. Fagerholm V. Scheinin M. 2003 Regional distribution of alpha (2C)-adrenoceptors in brain and spinal cord of control mice and transgenic mice overexpressing the alpha (2C)-subtype: an autoradiographic study with [(3) H]RX821002 and [(3) H]rauwolscine Neuroscience 117 875 898
26. Ihalainen JA. Tanila H. 2002 In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex EurJNeurosci 15 1789 1794
27. Ihalainen JA. Tanila H. 2004 In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens JNeurochem 91 49 56
28. Inderwies T. Pfaffl MW. Meyer HH. Blum JW. Bruckmaier RM. 2003 Detection and quantification of mRNA expression of alpha- and beta-adrenergic receptor subtypes in the mammary gland of dairy cows DomestAnimEndocrinol 24 123 135
29. Katona CL. Theodorou AE. Horton RW. 1987 Alpha 2-adrenoceptors in depression PsychiatrDev 5 129 149
30. Lakhlani PP. MacMillan LB. Guo TZ. McCool BA. Lovinger DM. Maze M. Limbird LE. 1997 Substitution of a mutant alpha2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo ProcNatl AcadSciUSA 94 9950 9955
31. Lindvall O. Bjorklund A. 1983 Chemical Neuroanatomy, pp. 225 229 Raven Press Ltd New York
32. Ma CL. Arnsten AF. Li BM. 2005 Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys BiolPsychiatry 57 192 195
33. Mongeau R. de Montigny C. Blier P. 1994 Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration Neuropsychopharmacology 10 41 51
34. Mongeau R. Blier P. de Montigny C. 1997 The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments Brain ResBrain ResRev 23 145 195
35. Moron JA. Brockington A. Wise RA. Rocha BA. Hope BT. 2002 Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines JNeurosci 22 389 395
36. O'Rourke MF. Blaxall HS. Iversen LJ. Bylund DB. 1994 Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes JPharmacolExpTher 268 1362 1367
37. Paczkowski FA. Bönisch H. Bryan-Lluka LJ. 2002 Pharmacological properties of the naturally occurring Ala (457) Pro variant of the human norepinephrine transporter Pharmacogenetics 12 165 173
38. Pattyn F. Speleman F. De Paepe A. Vandesompele J. 2003 RTPrimerDB: the real-time PCR primer and probe database NuclAcids Res 31 122 123
39. Paxinos G. Franklin KBJ. 2001 The Mouse Brain in Stereotaxic Coordinates 2nd edn Academic Press San Diego
40. Pfaffl MW. 2001 A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 e45
41. Philipp M. Brede M. Hein L. 2002 Physiological significance of alpha (2)-adrenergic receptor subtype diversity: one receptor is not enough AmJPhysiolRegulIntegrCompPhysiol 283 R287 R295
42. Porsolt RD. 2000 Animal models of depression: utility for transgenic research RevNeurosci 11 53 58
43. Pörzgen P. Bönisch H. Brüss M. 1995 Molecular cloning and organization of the coding region of the human norepinephrine transporter gene BiochemBiophysResCommun 215 1145 1150
44. Ressler KJ. Nemeroff CB. 1999 Role of norepinephrine in the pathophysiology and treatment of mood disorders BiolPsychiatry 46 1219 1233
45. Sacchetti G. Bernini M. Gobbi M. Parini S. Pirona L. Mennini T. Samanin R. 2001 Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors Naunyn Schmiedebergs ArchPharmacol 363 66 72
46. Sallinen J. Link RE. Haapalinna A. et al. 1997 Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist MolPharmacol 51 36 46
47. Sallinen J. Haapalinna A. MacDonald E. Viitamaa T. Lahdesmaki J. Rybnikova E. Pelto-Huikko M. Kobilka BK. Scheinin M. 1999 Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels MolPsychiatry 4 443 452
48. Schatzberg A. Schildkraut D. 1995 Recent studies on norepinephrine system in mood disorders, in Psychopharmacology: the Fourth Generation of Progress Bloom F. Kupfer D., eds), pp. 911 920 Raven Press Ltd New York
49. Scheibner J. Trendelenburg AU. Hein L. Starke K. 2001 Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice BrJPharmacol 132 925 933
50. Scheinin M. Sallinen J. Haapalinna A. 2001 Evaluation of the alpha2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models Life Sci 68 2277 2285
51. Schoffelmeer AN. Mulder AH. 1982 3H-Noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment Naunyn Schmiedebergs ArchPharmacol 318 173 180
52. Schramm NL. McDonald MP. Limbird LE. 2001 The alpha (2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety JNeurosci 21 4875 4882
53. Shannon JR. Flattem NL. Jordan J. Jacob G. Black BK. Biaggioni I. Blakely RD. Robertson D. 2000 Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency N EnglJMed 342 541 549
54. Siever LJ. Trestman RL. Coccaro EF. Bernstein D. Gabriel SM. Owen K. Moran M. Lawrence T. Rosenthal J. Horvath TB. 1992 The growth hormone response to clonidine in acute and remitted depressed male patients Neuropsychopharmacology 6 165 177
55. Simson PG. Weiss JM. Hoffman LJ. Ambrose MJ. 1986 Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus Neuropharmacology 25 385 389
56. Szabo ST. Blier P. 2001 Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus Neuropsychopharmacology 25 845 857
57. Vandesompele J. De Preter K. Pattyn F. Poppe B. Van Roy N. De Paepe A. Speleman F. 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3, RESEARCH0034q3.
58. Vizi ES. Zsilla G. Caron MG. Kiss JP. 2004 Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors JNeurosci 24 7888 7894
59. Wang R. MacMillan LB. Fremeau RT. Jr. Magnuson MA. Lindner J. Limbird LE. 1996 Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: evaluation of spatial and temporal information imparted by 3 kb of 5′ regulatory sequence for the alpha 2A AR-receptor gene in transgenic animals Neuroscience 74 199 218
60. Wang YM. Gainetdinov RR. Fumagalli F. Xu F. Jones SR. Bock CB. Miller GW. Wightman RM. Caron MG. 1997 Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine Neuron 19 1285 1296
61. Wang YM. Xu F. Gainetdinov RR. Caron MG. 1999 Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene BiolPsychiatry 46 1124 1130
62. Weiss JM. Simson PG. Hoffman LJ. Ambrose MJ. Cooper S. Webster A. 1986 Infusion of adrenergic receptor agonists and antagonists into the locus coeruleus and ventricular system of the brain. Effects on swim-motivated and spontaneous motor activity Neuropharmacology 25 367 384
63. Xu F. Gainetdinov RR. Wetsel WC. Jones SR. Bohn LM. Miller GW. Wang YM. Caron MG. 2000 Mice lacking the norepinephrine transporter are supersensitive to psychostimulants1 NatNeurosci 3 465 471
64. Yavich L. Lappalainen R. Sirvio J. Haapalinna A. MacDonald E. 1997 Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum EurJPharmacol 339 113 119
65. Yoshioka M. Matsumoto M. Numazawa R. Togashi H. Smith CB. Saito H. 1995 Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment EurJPharmacol 294 565 570